Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, GABA | 5 | 2021 | 25 | 1.800 |
Why?
|
| Manganese | 3 | 2019 | 87 | 1.290 |
Why?
|
| Lead | 3 | 2016 | 93 | 1.060 |
Why?
|
| Uterine Rupture | 1 | 2023 | 4 | 0.920 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2022 | 18 | 0.840 |
Why?
|
| Premature Birth | 1 | 2023 | 75 | 0.830 |
Why?
|
| Pregnancy Complications | 1 | 2023 | 126 | 0.820 |
Why?
|
| Brain | 9 | 2021 | 1346 | 0.810 |
Why?
|
| Bronchitis, Chronic | 1 | 2021 | 15 | 0.800 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 61 | 0.790 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 131 | 0.720 |
Why?
|
| Frontal Lobe | 1 | 2019 | 48 | 0.670 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 225 | 0.670 |
Why?
|
| Central Nervous System Diseases | 1 | 2018 | 29 | 0.640 |
Why?
|
| Positron-Emission Tomography | 7 | 2021 | 80 | 0.620 |
Why?
|
| Dopamine | 2 | 2019 | 245 | 0.610 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 75 | 0.580 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 664 | 0.570 |
Why?
|
| Synaptic Vesicles | 1 | 2016 | 31 | 0.570 |
Why?
|
| Presynaptic Terminals | 1 | 2016 | 53 | 0.550 |
Why?
|
| Synapses | 1 | 2016 | 180 | 0.510 |
Why?
|
| Receptors, GABA-A | 3 | 2018 | 64 | 0.480 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 360 | 0.470 |
Why?
|
| Hippocampus | 1 | 2016 | 561 | 0.440 |
Why?
|
| Lead Poisoning | 1 | 2013 | 26 | 0.440 |
Why?
|
| Schizophrenia | 1 | 2013 | 76 | 0.430 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 137 | 0.420 |
Why?
|
| Behavior, Animal | 1 | 2013 | 314 | 0.380 |
Why?
|
| Animals | 12 | 2021 | 15081 | 0.350 |
Why?
|
| Infant, Newborn | 2 | 2023 | 894 | 0.350 |
Why?
|
| Pregnancy | 2 | 2023 | 1549 | 0.300 |
Why?
|
| Humans | 13 | 2023 | 37093 | 0.230 |
Why?
|
| Hysterectomy | 1 | 2023 | 28 | 0.230 |
Why?
|
| Simian immunodeficiency virus | 1 | 2003 | 59 | 0.210 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2003 | 57 | 0.210 |
Why?
|
| Neuroglia | 2 | 2018 | 124 | 0.210 |
Why?
|
| Cadmium | 1 | 2021 | 58 | 0.200 |
Why?
|
| Gestational Age | 1 | 2022 | 190 | 0.200 |
Why?
|
| Pyrimidines | 5 | 2017 | 118 | 0.200 |
Why?
|
| Acetamides | 4 | 2017 | 11 | 0.190 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 242 | 0.180 |
Why?
|
| Pyrazoles | 4 | 2017 | 85 | 0.180 |
Why?
|
| Adult | 5 | 2023 | 11712 | 0.170 |
Why?
|
| AIDS Dementia Complex | 2 | 2014 | 102 | 0.170 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 64 | 0.170 |
Why?
|
| Receptors, Dopamine | 1 | 2019 | 25 | 0.170 |
Why?
|
| Pilot Projects | 3 | 2017 | 661 | 0.170 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2016 | 35 | 0.170 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 49 | 0.160 |
Why?
|
| Inflammation | 2 | 2016 | 618 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 481 | 0.160 |
Why?
|
| Football | 2 | 2017 | 10 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2021 | 308 | 0.160 |
Why?
|
| Female | 6 | 2023 | 20969 | 0.160 |
Why?
|
| Athletes | 2 | 2017 | 56 | 0.150 |
Why?
|
| Attention | 1 | 2019 | 156 | 0.150 |
Why?
|
| Prospective Studies | 1 | 2021 | 1378 | 0.150 |
Why?
|
| Mice | 4 | 2017 | 5913 | 0.150 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2026 | 0.150 |
Why?
|
| Prevalence | 1 | 2021 | 1455 | 0.150 |
Why?
|
| Vehicle Emissions | 1 | 2016 | 23 | 0.140 |
Why?
|
| Young Adult | 3 | 2023 | 4268 | 0.140 |
Why?
|
| Rats, Long-Evans | 1 | 2016 | 89 | 0.140 |
Why?
|
| Risk Factors | 2 | 2023 | 3562 | 0.140 |
Why?
|
| Hazardous Substances | 1 | 2016 | 18 | 0.140 |
Why?
|
| Animals, Newborn | 1 | 2017 | 343 | 0.140 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 143 | 0.140 |
Why?
|
| Brain Chemistry | 1 | 2016 | 140 | 0.140 |
Why?
|
| Random Allocation | 1 | 2016 | 139 | 0.140 |
Why?
|
| Brain Concussion | 1 | 2017 | 29 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2721 | 0.140 |
Why?
|
| Toxicology | 1 | 2015 | 8 | 0.140 |
Why?
|
| Nervous System | 1 | 2015 | 29 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 1609 | 0.130 |
Why?
|
| Air Pollutants | 1 | 2016 | 94 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2018 | 309 | 0.120 |
Why?
|
| Neuropsychological Tests | 4 | 2017 | 259 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 1371 | 0.120 |
Why?
|
| Portacaval Shunt, Surgical | 1 | 2013 | 1 | 0.120 |
Why?
|
| Hepatic Encephalopathy | 1 | 2013 | 11 | 0.120 |
Why?
|
| Radiopharmaceuticals | 2 | 2014 | 55 | 0.110 |
Why?
|
| Reflex, Abnormal | 1 | 2013 | 1 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 95 | 0.110 |
Why?
|
| Cerebral Ventricles | 1 | 2013 | 23 | 0.110 |
Why?
|
| Rats | 3 | 2016 | 3483 | 0.110 |
Why?
|
| Age Factors | 1 | 2016 | 1033 | 0.110 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 80 | 0.110 |
Why?
|
| Male | 7 | 2017 | 20025 | 0.110 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2011 | 10 | 0.100 |
Why?
|
| Air Pollutants, Occupational | 1 | 2011 | 9 | 0.100 |
Why?
|
| Manganese Poisoning | 1 | 2011 | 22 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2013 | 305 | 0.100 |
Why?
|
| Microglia | 3 | 2014 | 166 | 0.100 |
Why?
|
| Occupational Diseases | 1 | 2011 | 47 | 0.100 |
Why?
|
| Isoquinolines | 3 | 2013 | 45 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2016 | 400 | 0.100 |
Why?
|
| Occupational Exposure | 1 | 2011 | 79 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1015 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2016 | 938 | 0.090 |
Why?
|
| Sex Factors | 1 | 2013 | 898 | 0.090 |
Why?
|
| Molecular Probes | 1 | 2009 | 23 | 0.090 |
Why?
|
| Carbon Radioisotopes | 3 | 2017 | 11 | 0.080 |
Why?
|
| Neoplasms | 1 | 2016 | 1103 | 0.070 |
Why?
|
| Macaca nemestrina | 1 | 2003 | 1 | 0.060 |
Why?
|
| Encephalitis, Viral | 1 | 2003 | 6 | 0.060 |
Why?
|
| Gliosis | 1 | 2003 | 24 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2015 | 753 | 0.050 |
Why?
|
| Phenotype | 2 | 2014 | 689 | 0.050 |
Why?
|
| Macrophages | 1 | 2003 | 439 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2005 | 803 | 0.040 |
Why?
|
| Retirement | 1 | 2017 | 10 | 0.040 |
Why?
|
| Aryldialkylphosphatase | 1 | 2016 | 10 | 0.040 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2016 | 17 | 0.040 |
Why?
|
| Government Agencies | 1 | 2016 | 10 | 0.030 |
Why?
|
| Osteopontin | 1 | 2016 | 36 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 76 | 0.030 |
Why?
|
| Particulate Matter | 1 | 2016 | 51 | 0.030 |
Why?
|
| United States | 2 | 2017 | 4223 | 0.030 |
Why?
|
| Particle Size | 1 | 2016 | 215 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 173 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 306 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2015 | 142 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2016 | 230 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 42 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 333 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 400 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 157 | 0.030 |
Why?
|
| Carbon Isotopes | 1 | 2014 | 38 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2016 | 387 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 513 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2016 | 933 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2013 | 129 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1130 | 0.030 |
Why?
|
| Middle Aged | 3 | 2014 | 10129 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2013 | 233 | 0.030 |
Why?
|
| Imidazoles | 1 | 2013 | 126 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 739 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 122 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 147 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 602 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 626 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 1492 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 935 | 0.030 |
Why?
|
| Public Health | 1 | 2016 | 372 | 0.030 |
Why?
|
| Occupational Health | 1 | 2011 | 29 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2011 | 47 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2011 | 79 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 730 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 134 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 116 | 0.020 |
Why?
|
| Pneumonia | 1 | 2009 | 54 | 0.020 |
Why?
|
| Child | 1 | 2016 | 3131 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 1908 | 0.020 |
Why?
|
| Aged | 1 | 2014 | 6741 | 0.010 |
Why?
|